September 25, 2007 - Findings in a new study, published in the February 2007 issue of Lasers in Surgery and Medicine, suggest a new way to help protect the skin during radiation therapy.

Conducted by Maitland DeLand M.D., oncologist and president of OncoLogics Inc., the study illustrates how GentleWaves LED Photomodulation, manufactured by Light BioScience, significantly reduced the incidence and degree of radiation-induced dermatitis.

Radiation therapy (RT) is a key component in the treatment of breast cancer; however, a common adverse effect associated with RT is acute radiation dermatitis. Despite modern techniques, radiation-induced dermatitis develops in an estimated 87% of breast cancer patients treated with RT. When skin reactions are severe, it may be necessary to interrupt or even stop RT permanently.

Dr. DeLand chose to experiment with the LED Photomodulation technology because it was being used by dermatologists to improve skin quality, elasticity, tone and texture. In addition, research had shown that GentleWaves is safe, non-invasive and an easy-to-use treatment that can be used on all skin types.

In the study, 47 patients each received an average of 28 radiation treatments over a 5 to 6-week period. Patients were staged before enrollment and all Fitzpatrick skin types were accepted. Patients were placed into LED and control categories on the basis of clinical data obtained by retrospective review. All patients had breast conservation surgery and histopathically proven primary breast adenocarinoma (malignant tumor) with or without lymph metastases.

Nineteen patients received GentleWaves LED Photomodulation treatment immediately after RT and for the entire period of RT. Age-matched controls were treated under identical IMRT (intensity-modulated radiation treatment) protocol without LED Photomodulation. Skin reactions were graded weekly and at the end of the final treatment to the entire breast. The number of occasions on which patients had to stop receiving RT was also recorded.

The study found that LED Photomodulation decreased the inflammation and much of the discomfort reported after radiation. After treating with GentleWaves post-radiation, none of the patients incurred moist reactions or peeled skin and only one experienced moderate erythema.

For more information: www.lightbioscience.com


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now